Karsten Gavenis
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Validation of the TheraSure CNI-Monitor Under Immuno-checkpoint-therapy (Hereinafter: "Immunotherapy") in NSCLC in Palliative Therapy (NCT05426668) | Karsten Gavenis | 2025-02-24 |
| A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3 (NCT04524208) | Karsten Gavenis | 2021-03-01 |
Track Karsten Gavenis automatically
Every clearance here is in the API, with alerts when new ones post.